Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.

Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.

Comparative two-dimensional proteome analysis was used to identify proteins differentially expressed in multiple clinical normal and breast cancer tissues. One protein, the expression of which was elevated in invasive ductal and lobular breast carcinomas when compared with normal breast tissue, was...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Adam, P, Berry, J, Loader, J, Tyson, K, Craggs, G, Smith, P, De Belin, J, Steers, G, Pezzella, F, Sachsenmeir, K, Stamps, A, Herath, A, Sim, E, O'Hare, M, Harris, A, Terrett, J
Natura:	Journal article
Lingua:	English
Pubblicazione:	2003

Documenti analoghi

Mapping the genes for arylamine N-acetyltransferases
di: Fakis, G
Pubblicazione: (2000)

Structure and mechanism of arylamine N-acetyltransferases.
di: Westwood, I, et al.
Pubblicazione: (2006)

Structural Studies on the Mycobacterial Arylamine N-Acetyltransferases
di: Abuhammad, A, et al.
Pubblicazione: (2010)

Arylamine N-acetyltransferase in adult mouse brain
di: Mo, M, et al.
Pubblicazione: (2004)

Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
di: Kawamura, A, et al.
Pubblicazione: (2003)

Expression of the genes for arylamine N-acetyltransferases in mice
di: Boukouvala, S, et al.
Pubblicazione: (2002)

Neuroendocrine expression of mouse arylamine N-acetyltransferase 2
di: Wakefield, L, et al.
Pubblicazione: (2006)

Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
di: Sim, E, et al.
Pubblicazione: (2008)

Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
di: Laurieri, N, et al.
Pubblicazione: (2014)

Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.
di: Russell, A, et al.
Pubblicazione: (2009)

Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
di: Kawamura, A, et al.
Pubblicazione: (2005)

An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases.
di: Brooke, E, et al.
Pubblicazione: (2003)

Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status
di: Raúl A. Salazar-González, et al.
Pubblicazione: (2022-01-01)

Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.
di: Fullam, E, et al.
Pubblicazione: (2009)

Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.
di: Westwood, I, et al.
Pubblicazione: (2010)

Arylamine N-acetyltransferase expression during murine heart development
di: Wakefield, L, et al.
Pubblicazione: (2004)

Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population
di: Hiba Chelouti, et al.
Pubblicazione: (2017-08-01)

Biochemical Characterization of Arylamine N-acetyltransferases From Vibrio vulnificus
di: Xinning Liu, et al.
Pubblicazione: (2021-01-01)

Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.
di: Wang, H, et al.
Pubblicazione: (2005)

Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.
di: Abuhammad, A, et al.
Pubblicazione: (2010)

Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
di: Westwood, I, et al.
Pubblicazione: (2011)

Protein-ligand interactions of arylamine N-acetyltransferase from Mycobacterium smegmatis
di: Brooke, E
Pubblicazione: (2003)

Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer
di: Amjad Mahasneh, et al.
Pubblicazione: (2012-01-01)

Hamster arylamine N-acetyltransferase 2: Investigation of substrate specificity by high-through-put screening
di: Kawamura, A, et al.
Pubblicazione: (2004)

Humans and Chimpanzees Display Opposite Patterns of Diversity in Arylamine N-Acetyltransferase Genes
di: Christelle Vangenot, et al.
Pubblicazione: (2019-07-01)

Distribution of arylamine N-acetyltransferase 2 (NAT2) genotypes among Omanis
di: Musbah O. M. Tanira, et al.
Pubblicazione: (2003-04-01)

Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG.
di: Anderton, M, et al.
Pubblicazione: (2006)

The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
di: Sandy, J, et al.
Pubblicazione: (2002)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris.
di: Madikane, V, et al.
Pubblicazione: (2007)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris
di: Madikane, V, et al.
Pubblicazione: (2007)

Arylamine N-Acetyltransferases from mycobacteria: investigations of a potential yarget for anti-tubercular therapy
di: Abuhammad, A
Pubblicazione: (2013)

Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes
di: Mark A. Doll, et al.
Pubblicazione: (2017-07-01)

Characterization of the putative operon containing arylamine N−acetyltransferase (nat) in Mycobacterium bovis BCG
di: Eltis, E
Pubblicazione: (2006)

Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs).
di: Brooke, E, et al.
Pubblicazione: (2003)

Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.
di: Fullam, E, et al.
Pubblicazione: (2013)

Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.
di: Fullam, E, et al.
Pubblicazione: (2013)

A pilot study of the modulation of sirtuins on arylamine N-acetyltransferase 1 and 2 enzymatic activity
di: Eneida Turiján-Espinoza, et al.
Pubblicazione: (2018-03-01)

Small molecule colorimetric probes for specific detection of human arylamine N-acetyltransferase 1, a potential breast cancer biomarker.
di: Laurieri, N, et al.
Pubblicazione: (2010)

CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding.
di: Adam, P, et al.
Pubblicazione: (2006)

A novel color change mechanism for breast cancer biomarker detection: naphthoquinones as specific ligands of human arylamine N-acetyltransferase 1
di: Laurieri, N, et al.
Pubblicazione: (2013)